Primary Site >> Colorectal Cancer
Gene >> TFAP2E
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Recent patents and advances in genomic biomarker discovery for colorectal cancers. PMID: 20426761 |
Ref: TFAP2E-DKK4 and chemoresistance in colorectal cancer. PMID: 22216841 Ref: TFAP2E-DKK4 and chemoresistance in colorectal cancer. PMID: 22397669 |
Ref: TFAP2E hypermethylation was associated with survival advantage in patients with colorectal cancer. PMID: 24996990 |
Ref: Genome-wide screening of aberrant DNA methylation which associated with gene expression in mouse skin cancers. PMID: 24115114 Ref: TFAP2E methylation status and prognosis of patients with radically resected colorectal cancer. PMID: 25341849 Ref: Methylation changes in the TFAP2E promoter region are associated with BRAF mutation and poorer overall & disease free survival in colorectal cancer. PMID: 26097884 |
Ref: Transcription Factor AP2epsilon: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer. PMID: 25810491 |
Ref: TFAP2E Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal Cancer. PMID: 29535127 Ref: CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer. PMID: 29869456 |